HB3169, the SBIR/STTR Reauthorization Act of 2025, would reauthorize and substantially revise the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The bill extends core program authority, extends the FAST program, and raises required federal agency spending levels for SBIR/STTR over time. It also expands or creates several pilot and support initiatives, including fellowship and internship opportunities, application assistance, technical and business assistance, I-Corps participation, commercialization readiness programs, and a pilot to speed National Institutes of Health award processing.
The bill places a strong emphasis on commercialization and program administration. It requires new training for contracting and acquisition staff on Phase III awards, creates or designates Technology Commercialization Officials at participating agencies, expands Phase III transition support, and directs agencies to simplify solicitation and contract language. It also adds reporting and database requirements so Congress and the public can better track award timing, subcontracted research institutions, participant demographics, and commercialization outcomes. In addition, it codifies restrictions and safeguards for certain venture-capital-, hedge-fund-, and private-equity-backed firms, and it adds SBICs to the statutory framework.
The bill would amend multiple provisions of the Small Business Act, especially section 9, which governs SBIR and STTR. It would change agency funding minimums, extend several expiring pilot authorities through 2030 or later, and require the SBA and participating agencies to update policy directives, reporting systems, and public websites. It also broadens outreach to women, socially disadvantaged and economically disadvantaged individuals, minority institutions, Hispanic-serving institutions, Tribal Colleges and Universities, and other underrepresented groups, while directing assistance toward states that historically receive fewer awards.
Overall sentiment around the bill appears generally supportive and pro-expansion, based on the bill’s structure and stated goals, though no committee transcript or vote record was provided. The legislation is framed as a modernization and reauthorization measure intended to improve participation, speed, commercialization, and oversight rather than to scale back the programs. Because there are no recorded votes or hearing excerpts in the provided context, there is no documented opposition or formal bipartisan split to assess.
The main points of potential contention are likely to be the bill’s higher mandatory agency spending levels, the expanded administrative and reporting burdens, the new eligibility and foreign-ownership safeguards, and the broader role of federal agencies in directing commercialization and outreach. Stakeholders focused on small-business access and equity may favor the outreach and assistance provisions, while some agencies or industry groups may question the added compliance requirements, funding transfers, or restrictions on venture-backed firms.
The bill would amend the Small Business Act to extend and modify the SBIR and STTR programs, affecting federal agencies that participate in those programs, the SBA, small business award recipients, research subcontractors, and certain venture-capital- or private-equity-backed firms. It would increase required SBIR/STTR spending thresholds over time, extend multiple pilot authorities and deadlines, add new reporting and public disclosure requirements, and create new administrative roles and training obligations. It also changes eligibility and oversight rules, including national-security-related restrictions and expanded data collection on subcontractors and commercialization outcomes.
No committee transcripts or vote history were provided, so there is no recorded floor or committee sentiment to summarize. Based on the bill text, the measure is generally constructive and expansionary, with a clear policy focus on reauthorizing popular innovation programs, broadening participation, and improving commercialization and oversight. The absence of recorded opposition or amendments in the provided context suggests no documented controversy in the materials supplied, though the bill’s more prescriptive provisions could attract scrutiny from affected agencies or industry stakeholders.
Potential contention centers on several provisions: the scheduled increases in required agency SBIR/STTR spending; the transfer of administrative funds to the SBA; the new reporting and database obligations; the codified limits on awards to certain venture-capital-, hedge-fund-, or private-equity-backed firms tied to foreign-entity concerns; and the expanded federal role in commercialization and award processing. Supporters of broader participation and stronger oversight are likely to favor the outreach, fellowship, and transparency provisions, while agencies and some private-sector participants may object to added compliance costs, eligibility constraints, or reduced flexibility in award administration.